Vienna Science and Technology Fund

• Valeria Bordone

  Life Sciences 2022 - Public Health, Cognitive health in aging society - The role of context for cognitive functioning and related policy implications in Europe, LS22-008, 2023–2027, 1 Feb 2023

• University of Vienna

  Life Sciences 2022 - Public Health, Cognitive health in aging society - The role of context for cognitive functioning and related policy implications in Europe, LS22-008, 2023–2027, 1 Feb 2023

• International Institute for Applied Systems Analysis

  Life Sciences 2022 - Public Health, Cognitive health in aging society - The role of context for cognitive functioning and related policy implications in Europe, LS22-008, €529.9k, 2023–2027, Lead, 1 Feb 2023

• Adelheid Woehrer

  Life Sciences 2020, Decoding cellular senescence in glioblastoma (GlioAge), LS20-034, 2021–2025, 1 Oct 2021

• CeMM Research Center for Molecular Medicine

  Life Sciences 2020, Decoding cellular senescence in glioblastoma (GlioAge), LS20-034, 2021–2025, 1 Oct 2021

• Austrian Academy of Sciences

  Life Sciences 2020, Decoding cellular senescence in glioblastoma (GlioAge), LS20-034, 2021–2025, 1 Oct 2021

• University of Toronto

  Life Sciences 2020, Decoding cellular senescence in glioblastoma (GlioAge), LS20-034, 2021–2025, 1 Oct 2021

• Medical University of Vienna

  Life Sciences 2020, Decoding cellular senescence in glioblastoma (GlioAge), LS20-034, €899k, 2021–2025, Lead, 1 Oct 2021

• Georg Stary

  Life Sciences 2018 - Linking Research and Patients' Needs, Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice, LS18-058, 2019–2023, 1 Apr 2019

• CeMM Research Center for Molecular Medicine

  Life Sciences 2018 - Linking Research and Patients' Needs, Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice, LS18-058, 2019–2023, 1 Apr 2019

• Medical University of Vienna

  Life Sciences 2018 - Linking Research and Patients' Needs, Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice, LS18-058, 2019–2023, 1 Apr 2019

• Austrian Academy of Sciences

  Life Sciences 2018 - Linking Research and Patients' Needs, Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice, LS18-058, €799.6k, 2019–2023, Lead, 1 Apr 2019

• Peter Klimek

  Mathematics and ... 2016, Optimal gender-specific treatment paths on healthcare multiplex networks, MA16-045, 2017–2023, 1 Apr 2017

• Medical University of Vienna

  Mathematics and ... 2016, Optimal gender-specific treatment paths on healthcare multiplex networks, MA16-045, €645.8k, 2017–2023, 1 Apr 2017

Sources: openalex.org

• Human and mouse adrenal glands are characterized by species-specific steroidogenic states and tissue turnover

  8 Sept 2026

• Alterations in amygdala function explain how aging and loneliness impair trust learning

  WWTF VRG13-007, 14 Jan 2026

• Resource or crisis? Cognitive functioning after widowhood and why paid work status matters

  LS22-008, 2 Jan 2026

Sources: api.crossref.org